No abstract available
MeSH terms
-
Drug Resistance, Neoplasm / genetics
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
-
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
-
Precision Medicine
-
Recurrence
-
Rituximab
Grant support
Funding: The work was supported by the Research Council of Norway under the frame of ERA PerMed (to SSS, project number 322898), Lilly Constance og Karl Ingolf Larssons stiftelse (to SSS), and Stiftelsen Kristian Gerhard Jebsen (to GET and LAM, grant 19).